Yusuke Muto

19PUBLICATIONS
41CO-AUTHORS
Predictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursDental materials and equipment
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Aug 03, 2026
Cutaneous Squamous Cell Carcinoma Arising From Hidradenitis Suppurativa and Epidermal Cyst: Clinical Characteristics, Baseline Neutrophil-To-Lymphocyte Ratio, and Disease-Specific Survival in a Retrospective Cohort.

|Jan 08, 2026
Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol.

Taku Fujimura, Koji Yoshino, Hiroshi Kato

|Oct 28, 2025
Three Cases of Advanced Melanoma With Severe irAE Colitis With Rapid Tumor Progression Following Infliximab Administration.

Emi Yamazaki, Taku Fujimura, Yumi Kambayashi

|Sep 27, 2025
Plasminogen Activator Inhibitor-1 in Skin Malignancies: Therapeutic Implications of Its Inhibition.

Taku Fujimura, Yusuke Muto, Yoshihide Asano

|Jul 19, 2025
Secondary Publication of Japanese Dermatological Association Guidelines: Clinical Questions of Guidelines for Cutaneous Angiosarcoma 2025.

Yasuhiro Fujisawa, Yasuo Yoshioka, Koji Yoshino

|Jul 12, 2025
Recent Advances in Immunotherapy for Melanoma: Perspectives on the Development of Novel Treatments: A Mini Review.

Yusuke Muto, Taku Fujimura, Yoshihide Asano

Pageof 4

Frequent Collaborators

10 joint publications

Taku Fujimura

9 joint publications

Yoshihide Asano

7 joint publications

Naoya Yamazaki

6 joint publications

Kenjiro Namikawa